Dosing schedule of oral valacyclovir for prevention of herpes simplex virus [1]

Bone Marrow Transplantation

Volumn 32, Issue 10, 2003, Pages 1035-

  Moloney, M ^a   Prince, H M ^a   Seymour, J F ^a   Slavin, M ^a   Dooley, M ^a  

^a PETER MACCALLUM CANCER CENTRE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; STEROID; VALACICLOVIR;

AUTOTRANSPLANTATION; CHEMOTHERAPY; DRUG EFFICACY; DRUG USE; FOLLOW UP; HERPES SIMPLEX; HERPES SIMPLEX VIRUS; HUMAN; INCIDENCE; LETTER; MUCOSA INFLAMMATION; PRIORITY JOURNAL; SEROLOGY; STEM CELL TRANSPLANTATION; THROMBOTIC THROMBOCYTOPENIC PURPURA;

ACYCLOVIR; ADMINISTRATION, ORAL; DRUG ADMINISTRATION SCHEDULE; DRUG EVALUATION; HERPES SIMPLEX; HUMANS; TREATMENT OUTCOME; VALINE;

EID: 0344034829     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1704262     Document Type: Letter

References (5)

1. Eisen D, Essell J, Broun ER et al. Clinical utility of oral valacyclovir compared with oral acyclovir for the prevention of herpes simplex virus mucositis following autologous bone marrow transplantation or stem cell rescue therapy. Bone Marrow Transplant 2003; 31: 51-55.
2. Warkentin DI, Epstein JB, Campbell LM et al. Valacyclovir versus acyclovir for HSV prophylaxis in neutropenic patients. Ann Pharmacother 2002; 36: 1525-1531.
3. Liesveld JL, Abboud CN, Ifthikharuddin JJ et al. Oral valacyclovir versus intravenous acyclovir in preventing herpes simplex virus infections in autologous stem cell transplant recipients. BiolBlood Marrow Transplant 2002; 8: 662-665.
4. Moloney M, Prince HM, Seymour JF et al. Low dose valacyclovir for the prevention of HSV reactivation following transplant or chemotherapy. Proceedings of the 2002 Haematological Society of Australia and New Zealand (HSANZ) Annual Scientitic Meeting, Adelaide, Australia. September 2002, p. 380 (Abstract B184) http://www.hsanz.org.au/pdf/2000abstracts.pdf.
5. Fernandes C, SlaVin M, Prince HM et al. Low dose acyclovir prophylaxis is ineffective for the prevention of HSV infections following transplant and chemotherapy. Proceedings of the 2000 Haematological Society of Australia and New Zealand (HSANZ) Annual Scientific Meeting (Abstract 33) Perth, Australia, URL: http://www.hsanz.org.au/pdf/2000abstracts.pdf.